Sellas Life Sciences Group, Inc.
SLS
Revenue
0.00
0.000.00%
3 Months ChangeAssets
51.56M
▲19.25M▲59.59%
3 Months ChangeLiabilities
5.93M
▼-231.00k▼-3.75%
3 Months ChangeFree Cash Flow
-13.22M
▼-1.65M▼-14.24%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-08
Form 8-K
ID: 0001104659-26-001957
2025-11-12
Form 8-K
ID: 0001390478-25-000021
2025-11-12
Form 10-Q
ID: 0001390478-25-000020
2025-10-27
Form 8-K
ID: 0001104659-25-102345
2025-10-03
Form 8-K
ID: 0001104659-25-096643
2025-09-11
Form 8-K
ID: 0001104659-25-089272
2025-08-12
Form 8-K
ID: 0001390478-25-000017
2025-08-12
Form 10-Q
ID: 0001390478-25-000016
2025-06-18
Form 8-K
ID: 0001104659-25-060704
2025-06-06
Form 8-K
ID: 0001104659-25-057308